AIM-Ex
Oncology (Expression Reconstruction)
Key Facts
About Zephyr AI
Zephyr AI is a private, precision medicine company applying interpretable AI to large-scale, real-world data to advance drug discovery and diagnostics in oncology and metabolic diseases. The company's core offering is an integrated platform combining multi-modal AI tools (AIM Suite), a vast real-world data intelligence engine (Nexus), and deeply profiled oncology cohorts, all delivered on secure, enterprise-grade infrastructure. Zephyr operates as a B2B platform and services partner for biopharma and diagnostics companies, helping them accelerate development and reduce risk. Founded in 2020, the company is likely in an early-revenue stage, collaborating with partners to fine-tune and deploy its AI models.
View full company profile